Diagnosis, Labs, and Finding the Source
At a Glance
Ovarian stromal hyperthecosis is evaluated by confirming excess testosterone, checking whether androgens come from the ovaries or adrenal glands, and using ultrasound or MRI to look for tumors. When surgery occurs, pathology can confirm the diagnosis by examining ovarian tissue.
Confirming a diagnosis of ovarian stromal hyperthecosis (OH) is often a step-by-step process of “ruling out” more common or urgent conditions. Because OH shares features with both PCOS and certain rare tumors, doctors rely on a combination of highly precise blood tests and detailed imaging [1][2].
The Essential Blood Tests
When your body is producing too much androgen, the first goal is to find the “engine” driving it. Your care team will likely order a panel of tests to see if the hormones are coming from your ovaries or your adrenal glands [3]. Before testing, it is critical to report any supplements (such as over-the-counter DHEA), bodybuilding supplements, anabolic steroids, or hormonal creams you use, as these can severely elevate your lab results [4].
- Total Testosterone (via LC-MS/MS): This is the most critical test. Standard hormone tests (immunoassays) used for women are sometimes inaccurate near the female reference range. LC-MS/MS (Liquid Chromatography-Mass Spectrometry) is the “gold standard” laboratory method for measuring testosterone precisely [5][6].
- DHEA-S: This hormone is made almost entirely by the adrenal glands. If your DHEA-S is highly elevated (often over 700 μg/dL, though thresholds vary by age and lab), doctors will look more closely at your adrenal glands rather than your ovaries [3][7]. However, a normal DHEA-S does not absolutely exclude an adrenal issue.
- SHBG and Free Testosterone: Measuring Sex Hormone Binding Globulin (SHBG) helps doctors calculate your “free” (active) testosterone, which provides a clearer picture of how much hormone is actually affecting your body [5]. (Note that calculated free testosterone is often preferred because direct assays can be unreliable).
- Other Labs: You may also have tests for Androstenedione, 17-hydroxyprogesterone (to evaluate for nonclassic congenital adrenal hyperplasia rather than ruling out the adrenals entirely), and LH/FSH (to assess your menopausal status) [3][8].
Imaging: Looking for the Source
Once high testosterone is confirmed, the next step is imaging to see what the ovaries look like. The goal here is primarily to look for a virilizing ovarian tumor [9].
- Transvaginal Ultrasound: This is usually the first imaging tool used. In hyperthecosis, the ovaries may look entirely normal, or they may appear uniformly enlarged and solid. They typically do not have the specific fluid-filled sacs seen in PCOS [10][11].
- Pelvic MRI: An MRI provides a more detailed view. It can help distinguish between homogeneous (uniform) enlargement—which points toward hyperthecosis—and a specific nodule or mass on one side, which could indicate a tumor [2][12].
- Adrenal Imaging (CT or MRI): If your DHEA-S levels are high or adrenal sources are suspected, your doctor may also order a scan of your midsection to check the adrenal glands [13].
It is important to know that imaging can sometimes be “negative” (normal) even when hyperthecosis or a small tumor is present, as the overactive cells or small tumors are often too small to see on a scan [14][10]. Also, hyperthecosis can sometimes affect just one ovary.
The “Gold Standard” Diagnosis: Histopathology
While labs and scans provide clues and a strong clinical working diagnosis, the definitive tissue diagnosis of ovarian stromal hyperthecosis is through histopathology—examining the ovary tissue under a microscope [1]. This usually happens after the ovaries have been surgically removed (oophorectomy) as part of a treatment decision [2].
A pathologist will look for:
- Luteinized Theca Cells: These are specific cells that have become enlarged and active, appearing as small “nests” or clusters within the ovary’s supportive tissue [1][15].
- Stromal Hyperplasia: An overall increase in the density and volume of the ovary’s supportive tissue [16].
- Bilateral Involvement: Unlike tumors, which are usually on one side, hyperthecosis frequently affects both ovaries [11][17].
Diagnostic Completeness Checklist
When reviewing your records or preparing for an appointment, check if you have the following information:
| Category | What to Look For | Why It Matters |
|---|---|---|
| Labs | Total Testosterone (LC-MS/MS method) | Ensures the hormone measurement is accurate [5]. |
| Labs | DHEA-S and 17-OHP | Guides evaluation for an adrenal source [3]. |
| Supplements | DHEA, anabolic steroids | These can artificially raise levels [4]. |
| Imaging | Description of ovary “laterality” | Notes if one or both ovaries are enlarged [11]. |
| Imaging | Presence or absence of a “nodule” | Helps distinguish between hyperthecosis and a tumor [2]. |
| Pathology | Mentions of “luteinized cells” or “nests” | Confirms the specific biological tissue cause [1]. |
Common questions in this guide
What blood tests help diagnose ovarian stromal hyperthecosis?
Why does the testosterone testing method matter?
What can a high DHEA-S result mean?
Can an ultrasound or MRI miss ovarian stromal hyperthecosis?
How is ovarian stromal hyperthecosis confirmed?
Can supplements or medications affect the hormone results?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Was my total testosterone measured using liquid chromatography-mass spectrometry (LC-MS/MS), and how does that affect the accuracy of the result?
- 2.Based on my DHEA-S levels and supplement history, what is your assessment of my adrenal glands?
- 3.If my ultrasound and MRI are both normal, but my testosterone remains elevated, what are our clinical options?
- 4.Do my ovaries show 'homogeneous enlargement,' or is there any sign of a specific nodule or growth?
- 5.If we proceed with surgery, will my tissue samples be sent to a pathologist to confirm the specific presence of luteinized theca cell nests?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (17)
- 1
Hyperthecosis: an underestimated nontumorous cause of hyperandrogenism.
Meczekalski B, Szeliga A, Maciejewska-Jeske M, et al.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2021; (37(8)):677-682 doi:10.1080/09513590.2021.1903419.
PMID: 33759685 - 2
Discriminating between virilizing ovary tumors and ovary hyperthecosis in postmenopausal women: clinical data, hormonal profiles and image studies.
Yance VRV, Marcondes JAM, Rocha MP, et al.
European journal of endocrinology 2017; (177(1)):93-102.
PMID: 28432270 - 3
Rare Conditions of Hyperandrogenism Through Lifespan: A Case Series.
Apostolopoulou M, Taayedi R, Sărac CP, Demtröder F
Case reports in endocrinology 2025; (2025()):8604843 doi:10.1155/crie/8604843.
PMID: 41358367 - 4
Postmenopausal hyperandrogenism.
Yoldemir T
Climacteric : the journal of the International Menopause Society 2022; (25(2)):109-117 doi:10.1080/13697137.2021.1915273.
PMID: 33988479 - 5
MANAGEMENT OF ENDOCRINE DISEASE Hyperandrogenic states in women: pitfalls in laboratory diagnosis.
Pugeat M, Plotton I, de la Perrière AB, et al.
European journal of endocrinology 2018; (178(4)):R141-R154.
PMID: 29453202 - 6
Apparent Hyperandrogenemia Due to Immunoassay Interference Resolved by Liquid Chromatography-Tandem Mass Spectrometry.
Huang D, Guo Z, Fan J, et al.
JCEM case reports 2025; (3(8)):luaf140 doi:10.1210/jcemcr/luaf140.
PMID: 40605979 - 7
Causes, Patterns, and Severity of Androgen Excess in 1205 Consecutively Recruited Women.
Elhassan YS, Idkowiak J, Smith K, et al.
The Journal of clinical endocrinology and metabolism 2018; (103(3)):1214-1223 doi:10.1210/jc.2017-02426.
PMID: 29342266 - 8
Androgen excess and diagnostic steroid biomarkers for nonclassic 21-hydroxylase deficiency without cosyntropin stimulation.
Turcu AF, El-Maouche D, Zhao L, et al.
European journal of endocrinology 2020; (183(1)):63-71.
PMID: 32487778 - 9
Approach to androgen excess in women: Clinical and biochemical insights.
Cussen L, McDonnell T, Bennett G, et al.
Clinical endocrinology 2022; (97(2)):174-186 doi:10.1111/cen.14710.
PMID: 35349173 - 10
Diagnostic pitfalls in ovarian androgen-secreting (Leydig cell) tumours: case series.
Fanta M, Fischerová D, Indrielle-Kelly T, et al.
Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 2019; (39(3)):359-364 doi:10.1080/01443615.2018.1517148.
PMID: 30428740 - 11
Ovarian stromal hyperthecosis: An underestimated virilizing disorder in postmenopausal women.
Boudaouara O, Sellami A, Roger P
Annales d'endocrinologie 2025; (86(5)):101800 doi:10.1016/j.ando.2025.101800.
PMID: 40513985 - 12
Bilateral Ovarian Leydig Cell Tumors in a Postmenopausal Woman Causing Hirsutism and Virilization.
Shakir MKM, Snitchler AN, Vietor NO, et al.
AACE clinical case reports 2021; (7(1)):26-28 doi:10.1016/j.aace.2020.11.004.
PMID: 33851015 - 13
Postmenopausal onset of androgen excess: a diagnostic and therapeutic algorithm based on extensive clinical experience.
Luque-Ramírez M, Nattero-Chávez L, Rodríguez-Rubio Corona C, et al.
Journal of endocrinological investigation 2024; (47(8)):2007-2020 doi:10.1007/s40618-023-02297-9.
PMID: 38349517 - 14
Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis.
Mamoojee Y, Ganguri M, Taylor N, Quinton R
Clinical endocrinology 2018; (88(1)):13-20 doi:10.1111/cen.13492.
PMID: 28980338 - 15
Postmenopausal Hyperandrogenism due to Ovarian Hyperthecosis.
Metzker LS, Ferreira LAC, Borges JCN, et al.
Case reports in obstetrics and gynecology 2023; (2023()):2783464 doi:10.1155/2023/2783464.
PMID: 36743832 - 16
Virilization and Enlarged Ovaries in a Postmenopausal Woman.
Guerrero J, Marcus JZ, Heller DS
International journal of surgical pathology 2017; (25(6)):507-508 doi:10.1177/1066896917713134.
PMID: 28585475 - 17
Ovarian Leydig Cell Tumor and Ovarian Hyperthecosis in a Postmenopausal Woman: A Case Report and Literature Review.
Bužinskienė D, Marčiukaitytė R, Šidlovska E, Rudaitis V
Medicina (Kaunas, Lithuania) 2023; (59(6)) doi:10.3390/medicina59061097.
PMID: 37374301
This page explains testing for ovarian stromal hyperthecosis for informational purposes only and does not constitute medical advice. Your treating clinician, pathologist, and imaging team should interpret your hormone results and scans in context.
Get notified when new evidence is published on ovarian stromal hyperthecosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.